Table 2.
Emetogenicity of chemotherapeutic agents (Adapted from [7])
| Emetogenic potential | Cytotoxic drug | Dosage |
|---|---|---|
| High | Cisplatin | >1,500 mg/m2 |
| Cyclophosphamide | ||
| Dacarbazine | ||
| Mechloretamine | ||
| Carmustine | ||
| Streptozotocin | ||
| Moderate | Cyclophosphamide | <1,500 mg/m2 |
| Carboplatin | ||
| Doxorubicin | ||
| Cytarabine | >1,000 mg/m2 | |
| Oxaliplatin | ||
| Ifosfamide | ||
| Daunorubicin | ||
| Epirubicin | ||
| Idarubicin | ||
| Irinotecan | ||
| Low | Paclitaxel | |
| Docetaxel | ||
| Mitoxantrone | ||
| Topotecan | ||
| Etoposide | ||
| Pemetrexed | ||
| Methotrexate | ||
| Mitomycin | ||
| Gemcitabine | >1,000 mg/m2 | |
| Cytarabine | ||
| 5-Fluorouracil | ||
| Bortezomib | ||
| Cetuximab | ||
| Trastuzumab | ||
| Minimal | Bleomycin | |
| Busulfan | ||
| 2-Chlorodeoxyadenosine | ||
| Fludarabine | ||
| Vinblastine | ||
| Vincristine | ||
| Vinorelbine | ||
| Bevacizumab |